Health Condition 1: null- Patients with oral cavity cancer
Conditions
Interventions
Intervention1: Dexmedetomidine 1.5mcg/kg: Dexmedetomidine in a dose of 1.5mcg/kg was given as intravenous infusion for 10min and then retrograde intubation was performed
Control Intervention1: Dexmed
Sponsors
Ashish Walian
Eligibility
Inclusion criteria
Inclusion criteria: 1- ASA class 1 and 2 patients 2- Mouth opening less then 2cm due to any pathology 3- MPG grade 3 and 4 4- Thyromental distance less then 4cm 5- Restricted cervical mobility due to bone and joint disorder
Exclusion criteria
Exclusion criteria: 1- Patient not giving consent to participate in the study 2- Patient with nasal mass 3- Patient with hypersensitivity to drug under study 4- Patients with history of ischemic heart disease 5- Patients with baseline heart rate less then 50bpm 6- morbidly obese patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 Heart rate 2 Systolic blood pressure 3 Diastolic blood pressure 4 Oxygen saturation 5 Observer assessment of sedation scoreTimepoint: Vitals were recorded every minute for 10min during dexmedetomidine infusion and at 0min 1min 5min 10min 15min during the intubation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Ease of intubation 2 Patient reaction to placement of guidewire and tracheal tube 3 Cough severity 4 patient tolerance to endotracheal tube 5 Intubation time 6 Recall of the procedure 7 Discomfort during the procedureTimepoint: At 1min, 5min, 10min, 15min of intubation and 24hours after surgery | — |
Countries
India
Contacts
Public ContactDr Tanmay Tiwari
King George Medical University
Outcome results
None listed